Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
about
Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver GraftsVirologic Tools for HCV Drug Resistance TestingResistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical ImplicationsTreating hepatitis C virus in children: time for a new paradigmA Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection.Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle.HCV treatment in children and young adults with HIV/HCV co-infection in Europe.Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice.Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype.Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C VirusNeutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection.Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots.Hepatitis C Virus Treatment Revolution: Eastern European Story.Evidence for deleterious hepatitis C virus quasispecies mutation loads that differentiate the response patterns in IFN-based antiviral therapy.Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis.Therapy: Avoiding treatment failures associated with HCV resistance.Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life
P2860
Q21131741-75442452-B890-49D4-9AB6-73EDC1DDC342Q26774374-4AC159D1-55DC-4967-8C70-ACE3B7F38541Q26777408-8F99A648-95F2-4533-BE44-F650C998A37BQ26851883-5A7B281C-2AA3-4755-A177-BFE43FFC4D29Q36743639-3AC61CE1-7DF8-46BF-ABC9-BE6B4ECFBB57Q36933403-F3E42BAB-E875-401F-B272-51D546683440Q37098372-2C61F081-6DE4-496D-9422-DE9747CF4ECCQ38701810-07E7CA2D-07C0-43C8-B387-9F54B1E3F46AQ38826176-8CB1CF79-E9FC-46F5-8233-2C34A1A1A31CQ38945754-C5198BCF-CC19-4E07-B2EA-CBDE32C7A3EAQ39301797-E82C82DB-4E0A-43FF-AFD4-9C96CE16151CQ39307349-BA5EA84B-2309-4459-893F-DB3B83F7ABB7Q40069643-EFA5C46D-4F37-4DBF-9359-88AA0511032BQ40271353-D873D9EC-9C45-4520-A199-18E79EC25039Q40341184-5A1138ED-004A-4F81-972C-D1BD943157D4Q40719246-26EFD719-72B5-4B13-8CB3-13AAA1B07ED6Q40736190-410697CE-8EB1-4B66-B487-18F1F4D7C0A7Q40809349-D97531CE-ABC7-4177-9417-35B4D3B639FEQ41036874-858FC43B-FC3B-4708-96D0-BAE93723D7C0Q41115175-F461D106-29C3-4DC1-8C89-909804A98746Q41147723-E8DC9807-4EFA-417C-A990-A6BC3C3DA358Q42984329-03C37FFA-EFDA-4C95-97F4-4940E11FBCE1Q55717379-350FB830-9C6B-4D6C-983E-4BCBC48D7AA5Q57296265-689DE006-9282-4CA3-8463-340DC92F2FD2
P2860
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
@ast
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
@en
type
label
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
@ast
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
@en
prefLabel
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
@ast
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
@en
P1433
P1476
Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.
@en
P304
P356
10.1053/J.GASTRO.2015.01.002
P407
P577
2015-01-07T00:00:00Z